Clinical Trial Update: Desvenlafaxine in Opioid-Dependent Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update involving desvenlafaxine in patients with depression and opioid dependence (including methadone treatment) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Opioid Dependence

Drugs mentioned

• Desvenlafaxine (Desvenlafaxine)

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Depression, Opioid Dependence | Phase 4 | Status: COMPLETED